RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Kaitai Capital
K

Kaitai Capital portfolio

Kaitai Capital has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $52M.
Latest deal: Rgenta Therapeutics · Nov 29, 2022.
About this page

Its most recent investment on record is Rgenta Therapeutics's $52M Series A round in November 2022, alongside Lilly Asia Ventures, CICC, Vivo Capital and 6 others. That company is in Health and bio. It has co-invested with Vivo Capital, Lilly Asia Ventures and CICC, most often Vivo Capital (2 rounds).

What Kaitai Capital invests in

How Kaitai Capital invests

StageDealsCapital in rounds
Series A 1 50%$52M
Seed 1 50%undisclosed
YearDealsCapital in rounds
2021 1 50%undisclosed
2022 1 50%$52M

Kaitai Capital portfolio companies

CompanyRound with Kaitai CapitalTotal raisedLatest raise
RRgenta Therapeutics
Health and bio
Series A · $52M$52MNov 29, 2022
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Kaitai Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Kaitai Capital, which is a subset of its real portfolio. API: /api/v1/investors/kaitai-capital (get a free API key). More: the most active VC firms and new venture capital funds.